PCK1 and metabolic dysfunction-associated steatotic liver disease: We identified a robust decrease in PCK1 expression in the livers of MAFLD mice and patients with NAFLD/NASH, causing severe hepatic steatosis and confirming that disordered hepatic gluconeogenesis affects lipid homeostasis.